POSITRON EMISSION TOMOGRAPHY IN PREDICTING RESPONSE IN PATIENTS WHO ARE UNDERGOING TREATMENT WITH PEMETREXED DISODIUM AND CISPLATIN WITH OR WITHOUT SURGERY FOR STAGE I, STAGE II, OR STAGE III NON-SMALL CELL LUNG CANCER: